QUARTERLY DATA (UNAUDITED) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands |
3 Months Ended | 12 Months Ended | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2023 |
Sep. 30, 2023 |
Jun. 30, 2023 |
Mar. 31, 2023 |
Dec. 31, 2022 |
Sep. 30, 2022 |
Jun. 30, 2022 |
Mar. 31, 2022 |
Dec. 31, 2023 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|
Quarterly Financial Information Disclosure [Abstract] | |||||||||||
Interest and dividend income | $ 150,537 | $ 148,021 | $ 145,425 | $ 132,316 | $ 121,384 | $ 103,671 | $ 87,379 | $ 74,823 | $ 576,299 | $ 387,257 | $ 329,065 |
Interest expense | 62,116 | 57,687 | 52,666 | 34,783 | 19,292 | 11,587 | 6,021 | 5,760 | 207,252 | 42,660 | 37,899 |
Net interest income | 88,421 | 90,334 | 92,759 | 97,533 | 102,092 | 92,084 | 81,358 | 69,063 | 369,047 | 344,597 | 291,166 |
Non-interest income | (8,383) | 17,465 | 17,094 | 16,606 | 15,654 | 16,251 | 16,351 | 20,681 | 42,782 | 68,937 | 143,248 |
Total net revenue | 80,038 | 107,799 | 109,853 | 114,139 | 117,746 | 108,335 | 97,709 | 89,744 | 411,829 | 413,534 | 434,414 |
Provision expense/(benefit) for credit losses | 7,000 | 8,000 | 8,000 | 8,999 | 12,000 | 3,000 | 0 | (4,000) | 31,999 | 11,000 | (500) |
Non-interest expense | 78,992 | 76,513 | 74,048 | 71,955 | 70,014 | 81,677 | 68,475 | 68,550 | 301,508 | 288,716 | 285,893 |
Income before income taxes | (5,954) | 23,286 | 27,805 | 33,185 | 35,732 | 23,658 | 29,234 | 25,194 | 78,322 | 113,818 | 149,021 |
Income tax (benefit)/expense | (4,509) | 3,741 | 3,944 | 5,548 | 5,227 | 4,941 | 6,119 | 4,998 | 8,724 | 21,285 | 30,357 |
Net income/(loss) | $ (1,445) | $ 19,545 | $ 23,861 | $ 27,637 | $ 30,505 | $ 18,717 | $ 23,115 | $ 20,196 | $ 69,598 | $ 92,533 | $ 118,664 |
Basic earnings per share (in USD per share) | $ (0.03) | $ 0.45 | $ 0.55 | $ 0.63 | $ 0.69 | $ 0.42 | $ 0.50 | $ 0.42 | $ 1.61 | $ 2.03 | $ 2.41 |
Diluted earnings per share (in USD per share) | $ (0.03) | $ 0.45 | $ 0.55 | $ 0.63 | $ 0.69 | $ 0.42 | $ 0.50 | $ 0.42 | $ 1.60 | $ 2.02 | $ 2.39 |
Weighted average common shares outstanding: | |||||||||||
Basic (in shares) | 42,852 | 43,164 | 43,443 | 43,693 | 44,105 | 44,700 | 45,818 | 47,668 | 43,288 | 45,564 | 49,240 |
Diluted (in shares) | 43,101 | 43,347 | 43,532 | 44,036 | 44,484 | 45,034 | 46,102 | 48,067 | 43,504 | 45,914 | 49,554 |
X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The net amount of operating interest income (expense). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Total aggregate amount of all noninterest expense. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The total amount of noninterest income which may be derived from: (1) fees and commissions; (2) premiums earned; (3) insurance policy charges; (4) the sale or disposal of assets; and (5) other sources not otherwise specified. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of credit loss expense (reversal of expense) for financing receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|